These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. DNM2 mutations in Chinese Han patients with centronuclear myopathy. Lin P; Liu X; Zhao D; Dai T; Wu H; Gong Y; Yan C Neurol Sci; 2016 Jun; 37(6):995-8. PubMed ID: 26908122 [TBL] [Abstract][Full Text] [Related]
5. A centronuclear myopathy-dynamin 2 mutation impairs skeletal muscle structure and function in mice. Durieux AC; Vignaud A; Prudhon B; Viou MT; Beuvin M; Vassilopoulos S; Fraysse B; Ferry A; Lainé J; Romero NB; Guicheney P; Bitoun M Hum Mol Genet; 2010 Dec; 19(24):4820-36. PubMed ID: 20858595 [TBL] [Abstract][Full Text] [Related]
6. Development of versatile allele-specific siRNAs able to silence all the dominant dynamin 2 mutations. Dudhal S; Mekzine L; Prudhon B; Soocheta K; Cadot B; Mamchaoui K; Trochet D; Bitoun M Mol Ther Nucleic Acids; 2022 Sep; 29():733-748. PubMed ID: 36090755 [TBL] [Abstract][Full Text] [Related]
7. Different in vivo impacts of dynamin 2 mutations implicated in Charcot-Marie-Tooth neuropathy or centronuclear myopathy. Massana Muñoz X; Buono S; Koebel P; Laporte J; Cowling BS Hum Mol Genet; 2019 Dec; 28(24):4067-4077. PubMed ID: 31628461 [TBL] [Abstract][Full Text] [Related]
8. Clinicopathological features of centronuclear myopathy in Japanese populations harboring mutations in dynamin 2. Mori-Yoshimura M; Okuma A; Oya Y; Fujimura-Kiyono C; Nakajima H; Matsuura K; Takemura A; Malicdan MC; Hayashi YK; Nonaka I; Murata M; Nishino I Clin Neurol Neurosurg; 2012 Jul; 114(6):678-83. PubMed ID: 22613877 [TBL] [Abstract][Full Text] [Related]
9. Nuclear defects in skeletal muscle from a Dynamin 2-linked centronuclear myopathy mouse model. Fongy A; Falcone S; Lainé J; Prudhon B; Martins-Bach A; Bitoun M Sci Rep; 2019 Feb; 9(1):1580. PubMed ID: 30733559 [TBL] [Abstract][Full Text] [Related]
10. Benefits of therapy by dynamin-2-mutant-specific silencing are maintained with time in a mouse model of dominant centronuclear myopathy. Trochet D; Prudhon B; Mekzine L; Lemaitre M; Beuvin M; Julien L; Benkhelifa-Ziyyat S; Bui MT; Romero N; Bitoun M Mol Ther Nucleic Acids; 2022 Mar; 27():1179-1190. PubMed ID: 35282416 [TBL] [Abstract][Full Text] [Related]
11. DNM2 levels normalization improves muscle phenotypes of a novel mouse model for moderate centronuclear myopathy. de Carvalho Neves J; Moschovaki-Filippidou F; Böhm J; Laporte J Mol Ther Nucleic Acids; 2023 Sep; 33():321-334. PubMed ID: 37547294 [TBL] [Abstract][Full Text] [Related]
12. Increased expression of wild-type or a centronuclear myopathy mutant of dynamin 2 in skeletal muscle of adult mice leads to structural defects and muscle weakness. Cowling BS; Toussaint A; Amoasii L; Koebel P; Ferry A; Davignon L; Nishino I; Mandel JL; Laporte J Am J Pathol; 2011 May; 178(5):2224-35. PubMed ID: 21514436 [TBL] [Abstract][Full Text] [Related]
13. A centronuclear myopathy-causing mutation in dynamin-2 disrupts neuronal morphology and excitatory synaptic transmission in a murine model of the disease. Arriagada-Diaz J; Flores-Muñoz C; Gómez-Soto B; Labraña-Allende M; Mattar-Araos M; Prado-Vega L; Hinostroza F; Gajardo I; Guerra-Fernández MJ; Bevilacqua JA; Cárdenas AM; Bitoun M; Ardiles AO; Gonzalez-Jamett AM Neuropathol Appl Neurobiol; 2023 Aug; 49(4):e12918. PubMed ID: 37317811 [TBL] [Abstract][Full Text] [Related]
14. Satellite cells deficiency and defective regeneration in dynamin 2-related centronuclear myopathy. F Almeida C; Bitoun M; Vainzof M FASEB J; 2021 Apr; 35(4):e21346. PubMed ID: 33715228 [TBL] [Abstract][Full Text] [Related]
15. A rare case of centronuclear myopathy with Aghbolaghi AG; Lechpammer M Autops Case Rep; 2017; 7(2):43-48. PubMed ID: 28740838 [TBL] [Abstract][Full Text] [Related]
16. Calcium homeostasis alterations in a mouse model of the Dynamin 2-related centronuclear myopathy. Fraysse B; Guicheney P; Bitoun M Biol Open; 2016 Nov; 5(11):1691-1696. PubMed ID: 27870637 [TBL] [Abstract][Full Text] [Related]
17. Imaging-based evaluation of pathogenicity by novel DNM2 variants associated with centronuclear myopathy. Fujise K; Okubo M; Abe T; Yamada H; Takei K; Nishino I; Takeda T; Noguchi S Hum Mutat; 2022 Feb; 43(2):169-179. PubMed ID: 34837441 [TBL] [Abstract][Full Text] [Related]
18. Subtle central and peripheral nervous system abnormalities in a family with centronuclear myopathy and a novel dynamin 2 gene mutation. Echaniz-Laguna A; Nicot AS; Carré S; Franques J; Tranchant C; Dondaine N; Biancalana V; Mandel JL; Laporte J Neuromuscul Disord; 2007 Dec; 17(11-12):955-9. PubMed ID: 17825552 [TBL] [Abstract][Full Text] [Related]